The MediPines Gas Exchange Monitor (AGM100®) empowers emergency medicine clinicians with a fast objective measurement of pulmonary gas exchange inefficiency. The AGM100® helps improve clinician confidence in determining which patients to admit in order to address gas exchange, and other related issues.
- Quickly separate respiratory from non-respiratory patients.
- Confidently determine if AECOPD patients require admission.
- Establish a baseline and evaluate patient response to therapy once treatment is given.
“A COPD patient developed acute exacerbation. We had less than 30 minutes to intervene and the MediPines Gas Exchange Monitor (AGM100®) made all the difference.”
“This is important not only to reduce the risk of infections and vascular or nerve damage with invasive sampling, it also helps to reduce the amount of blood collected for biochemical analyses. This is relevant as ~30% of blood transfusions in the ICU are caused by iatrogenic blood sampling (3). Noninvasive monitoring of pulmonary gas exchange may thus aid to save human blood products, which are a scarce resource, and increase patient safety by avoiding the deleterious negative association of blood transfusion with short-term (survival) and long-term (tumor frequencies) outcome.”*
The AGM100™ is not intended to replace arterial blood gas sampling for diagnosis or treatment purposes.
The MediPines Gas Exchange Monitor can provide the clinician with knowledge of possible respiratory distress. Oxygen saturation alone is not sufficient to determine Oxygen Deficit. Oxygen Deficit is a novel technique that is fully non-invasive.
“The MediPines Gas Exchange Monitor is so easy to use and portable. You get the data in minutes, instead of hours so I can separate ‘respiratory’ from ‘non-respiratory’ patients. It also worked seamlessly when I took it to remote rural areas where we did not have access to labs nearby…the next hospital is 160 miles away and the only way to transport patients to a hospital was via helicopter.” – Rural Physician